2026 Annual Meeting | PL2 - Hot Topics Plenary Session

Date Saturday 04/18/26

Time 04:45 PM - 05:45 PM CDT Add To Calendar

Location McCormick Place West | W375de

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Lilyana M. Amezcua, MD, FAAN

Topic(s) General Neurology, Aging, Dementia, and Behavioral Neurology, Multiple Sclerosis

Learning Objectives This session highlights the latest, cutting-edge translational research related to clinical issues of importance with three outstanding speakers providing summaries of their recent research findings and describing the clinical implications of the results.

CME Available 1.00 CME credit

Program Tracks Medical Students, Residents

Program Materials Program Evaluations

Event Timeline
04:45 PM - 05:05 PM CDT	Speaker	Preventing Dementia with Shingles Vaccination? Evidence from Quasi-randomized Vaccine Rollouts Pascal Geldsetzer, MD, PhD, MPH
05:05 PM - 05:25 PM CDT	Speaker	2024 McDonald Criteria for Multiple Sclerosis Olga Ciccarelli, MD, PhD, FRCP
05:25 PM - 05:45 PM CDT	Speaker	Blood-based Biomarkers in the Clinical Diagnosis of Alzheimer’s Disease Suzanne E. Schindler, MD, PhD

Faculty Disclosures
Lilyana M. Amezcua, MD, FAAN	Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
Suzanne E. Schindler, MD, PhD	Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Schindler has received research support from National Institute on Aging. Dr. Schindler has received personal compensation in the range of $0-$499 for serving as a Member of the Biospecimen Review Committee with National Centralized Repository for Alzheimer Disease. Dr. Schindler has a non-compensated relationship as a Board Member with Greater Missouri Alzheimer's Association that is relevant to AAN interests or activities.
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Pascal Geldsetzer, MD, PhD, MPH	The institution of Dr. Geldsetzer has received research support from National Institutes of Health. The institution of Dr. Geldsetzer has received research support from Biohub – San Francisco. Dr. Geldsetzer has a non-compensated relationship as a Advisory board member with GSK that is relevant to AAN interests or activities.